Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease

Neurology

Volumn 58, Issue 2, 2002, Pages 192-197

  Otto, M ^a,b   Wiltfang, J ^a   Cepek, L ^a   Neumann, M ^b   Mollenhauer, B ^a   Steinacker, P ^a   Ciesielczyk, B ^a   Schulz Schaeffer, W ^a   Kretzschmar, H A ^b   Poser, S ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; PRION PROTEIN; PROTEIN 14 3 3; TAU PROTEIN; VALINE;

ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REFERENCE VALUE;

EID: 0037154135     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.2.192     Document Type: Article

References (45)

1. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease
2. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets
3. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
4. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects
5. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease
6. Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering
7. Epidemiology of Creutzfeldt-Jakob disease
8. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease
9. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease
10. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
11. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: Prospective case-control study
12. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease
13. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies
14. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients
15. Current clinical diagnosis in Creutzfeldt-Jakob disease: Identification of uncommon variants
16. Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies
17. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
18. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
19. Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
20. Tau in cerebrospinal fluid: A potential diagnostic in Alzheimer's disease
21. Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF
22. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: A study in Japan
23. Molecular genetics of human prion diseases in Germany
24. Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
25. Tau immunoreactivity detected in human plasma, but no obvious increase in dementia
26. Index rating for diagnostic tests
27. Cerebrospinal-fluid test for new variant Creutzfeldt-Jakob disease
28. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease
29. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: A community based follow up study
30. Increased cerebrospinal fluid tau in patients with Alzheimer's disease
31. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay
32. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease
33. Reduction of beta-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease
34. Decreased levels of Abeta 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
35. A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients
36. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology
37. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins
38. 14-3-3 Proteins on the MAP
39. 14-3-3 Proteins: Structure, function, and regulation
40. 14-3-3zeta is an effector of tau protein phosphorylation
41. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease
42. Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients
43. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: A sandwich ELISA with a synthetic phosphopeptide for standardization
44. Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease